SCHEMBL4370199

SCHEMBL4370199

CC(N)c1cccc(NS(C)(=O)=O)c1

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.52
ALDH1A1 P00352 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
POLB P06746 1/20 0.49
MAPKAPK2 P49137 1/20 0.48
KIF11 P52732 1/20 0.45
KDM1A O60341 1/20 0.44
NR3C1 P04150 1/20 0.44
BRD4 O60885 1/20 0.43
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
GRIA2 P42262 1/20 0.43
EGFR P00533 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10100499 0.85 KEAP1 (0.55) KEAP1ALDH1A1SMN1; SMN2POLBMAPKAPK2
SCHEMBL842032 0.84 HSD17B1 (0.50) KEAP1KIF11KDM1ABRD4HSD17B1
SCHEMBL860476 0.84 HSD17B1 (0.50) KEAP1KIF11KDM1ABRD4HSD17B1
SCHEMBL245468 0.82 MEN1 (0.60) KEAP1ALDH1A1SMN1; SMN2POLBMAPKAPK2
SCHEMBL244843 0.82 KEAP1 (0.52) KEAP1ALDH1A1SMN1; SMN2POLBMAPKAPK2
SCHEMBL9763858 0.81 ALDH1A1 (0.47) KEAP1ALDH1A1SMN1; SMN2POLBMAPKAPK2
SCHEMBL9005712 0.81 ALDH1A1 (0.47) KEAP1ALDH1A1SMN1; SMN2POLBMAPKAPK2
SCHEMBL10858563 0.81 ALDH1A1 (0.47) KEAP1ALDH1A1SMN1; SMN2POLBMAPKAPK2
SCHEMBL698855 0.80 KEAP1 (0.70) KEAP1ALDH1A1SMN1; SMN2POLBKIF11
SCHEMBL9654387 0.80 ALDH1A1 (0.46) KEAP1ALDH1A1SMN1; SMN2POLBMAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108929263-B Arylamide Kv2.1 inhibitor and preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2022-07-22 CN disclosed
CN-111108092-A Arylamide Kv2.1 inhibitor and preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2020-05-05 CN disclosed
CN-101619038-A Isoquinoline compound or salt thereof, medicinal composition, preparation method and application thereof SHANGHAI INST PHARM INDUSTRY 2010-01-06 CN disclosed
WO-2009012375-A2 SQUARATE KINASE INHIBITORS WYETH (US) 2009-01-22 WO disclosed